Partnership with Huwel Life Sciences
Avio Smart Market Stack Limited has entered into a strategic partnership with Huwel Life Sciences to support the scaling of affordable, high-quality diagnostic solutions. The collaboration focuses on expanding access, strengthening distribution, and enabling wider adoption of indigenously developed diagnostics across institutional and public health programs.
About Huwel Life Sciences
Huwel Lifesciences is an innovation-driven molecular diagnostics company focused on developing advanced RT-PCR and point-of-care diagnostic technologies. Its expanding portfolio supports infectious diseases, women's health, public health programmes, and precision healthcare through indigenous, scalable, and affordable diagnostic solutions.
Pandemic Response Excellence
Supported India's pandemic response by delivering more than 50 million molecular diagnostic tests, demonstrating the ability to scale rapidly during national public health emergencies.
Global Validation
Collaborates with leading international health organisations and has received support from globally recognised institutions, reflecting the quality and credibility of its diagnostic innovations.
World-Class Manufacturing
Operates advanced manufacturing facilities with internationally recognised quality standards, enabling large-scale production of high-quality molecular diagnostic solutions.
Flagship Innovation: Quantiplus® MTB FAST
Affordable Molecular TB Diagnosis
Quantiplus® MTB FAST is an ICMR-validated, open-system RT-PCR solution designed to enable rapid and affordable confirmatory testing for tuberculosis across diverse laboratory settings. It is approved by ICMR and was launched by the Union Health Minister.
Supporting India’s TB Elimination Mission
The solution is aligned with the objectives of the National TB Elimination Programme by expanding access to molecular testing, improving diagnostic capacity, and enabling wider use of existing RT-PCR infrastructure.
Designed for Scale and Accessibility
- Extraction-free workflow for faster and simpler testing
- Open-system compatibility with existing RT-PCR platforms
- Suitable for central laboratories and decentralised testing models
- Validated through multi-centre clinical evaluation
- Cost-efficient design for large public health programmes
A Strategic Partnership for Healthcare Innovation
Huwel Life Sciences Contributes
- Indigenous molecular diagnostic technologies
- Advanced RT-PCR and point-of-care platforms
- Strong research, product development, and manufacturing capabilities
- Broad portfolio across infectious diseases, women's health, and public health
- Proven expertise in developing scalable diagnostic solutions
Avio Contributes
- Strategic investments and capital support
- Commercialisation and market expansion
- Government and institutional partnerships
- Distribution, business development, and market access
- Long-term growth and global expansion strategy
Building the Future Together
Avio and Huwel are combining innovation, strategic investments, commercial execution, and global partnerships to accelerate the development, manufacturing, and international expansion of next-generation molecular diagnostic solutions.
Target Markets
Market Opportunity & Impact
Testing Scale
1.89 crore sputum tests + 68.3 lakh NAATs in 2023 alone through NTEP.
Quality Gap
Need for reliable, validated, international-standard products at accessible prices.
Infrastructure
Growing network requiring point-of-care solutions for remote areas.
Aligned with National Healthcare Priorities
- TB Mukt Bharat — Supporting wider adoption of molecular diagnostics for faster and more accurate tuberculosis detection.
- Ayushman Bharat — Enabling affordable, high-quality diagnostics that improve accessibility and strengthen public healthcare delivery.
- Make in India — Designing, developing, and manufacturing advanced diagnostic technologies within India for domestic and international markets.
- Digital Health Mission — Building technology-enabled diagnostic solutions that integrate with the evolving digital healthcare ecosystem.
"Our vision is to build a world-class healthcare platform by combining indigenous innovation with strategic investments and commercial excellence. Together with Huwel Lifesciences, we aim to expand access to advanced molecular diagnostics across India and international markets."N. Vidhya Sagar Reddy, Managing Director, Avio Smart Market Stack Limited